Novel MRPL13-ALK and PPP1CB-ALK Double Fusion As a Potential Mechanism of Acquired Resistance to First-Line Osimertinib in EGFR-Mutant High-Grade Neuroendocrine Tumor of the Lung

by Yuyan Jiao, MM, Ming Liu, MM, Ningning Luo, MS, Hao Guo, PhD, Jianzhe Li, PhD
Published 2020-11-01